TD0069
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TD0069, covering 2022-09-21 to 2022-09-21. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19 [Phase 3]